Study in JNCCN—Journal of the National Comprehensive Cancer Network, finds early dose reduction of adjuvant FEC-D chemotherapy negatively impacts overall survival rates for women with intermediate- or high-risk breast cancer.
The National Comprehensive Cancer Network® (NCCN®) publishes new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Small Bowel Adenocarcinoma (SBA). Updated NCCN Guidelines for Genetic/Familial Risk Assessment: Colorectal Cancer and Colorectal Cancer Screening clarify how to use genetic testing and screening to detect cancer in high-risk individuals at an earlier stage.
New research in JNCCN from the Hutchinson Institute for Cancer Outcomes Research (HICOR) within the Fred Hutch/University of Washington Cancer Consortium—part of the Seattle Cancer Care Alliance—identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
NCCN Policy Summit: The State of Cancer Care in America: The Impact of State Policy on Access to High Quality Cancer Care looks at federal waivers, shifting regulatory authority, and other ways that state policy is having a growing impact on access to high-quality cancer care.
New NCCN Guidelines for Patients: Bladder Cancer explains the lengthy surveillance process that follows active treatment for the sixth most-common cancer in the United States.
NCCN Oncology Research Program (ORP) issues request for proposals to improve quality of care for people with stage III, stage IV, and recurrent epithelial ovarian cancer.
New research from the Johns Hopkins Kimmel Cancer Center, published in the June 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, pilots multidisciplinary team approach for providing diagnosis and management of immunotherapy-related adverse events (irAEs).
The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) and AstraZeneca are collaborating to seek proposals for improving care processes for patients with unresectable stage III and stage IV non-small cell lung cancer (NSCLC).
National Comprehensive Cancer Network (NCCN) debuts NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Acute Lymphoblastic Leukemia (ALL)—comprehensive, up-to-date, evidence-based, consensus-driven guidelines for treating children with cancer outside of a clinical trial setting.
Researchers from University of Pennsylvania find adding bevacizumab to carboplatin-pemetrexed was effective in treating non-squamous non-small cell lung cancer, in new study published in JNCCN—Journal of the National Comprehensive Cancer Network.
The National Comprehensive Cancer Network announces 2019 Young Investigator Award recipients, and provides information about abstract poster presentations and fellows program from NCCN 2019 Annual Conference.
National Comprehensive Cancer Network to adapt NCCN Guidelines® for Breast, Cervical, and Rectal Cancer to better meet cancer burden and resource levels in Bolivia.
Researchers from Abramson Cancer Center at the University of Pennsylvania find patients who kept ice chips in their mouths during infusion with oxaliplatin reported less trouble eating and drinking than patients who were not exposed to this intervention. Randomized study published in JNCCN-Journal of the National Comprehensive Cancer Network.
CAR T-Cell therapy, immunotherapy, and other innovative cancer treatments were the focus of a patient-centered keynote and roundtable discussion at the NCCN 2019 Annual Conference (#NCCNac19)
ASCO, ASH, and NCCN receive letter clarifying CDC Guideline for Prescribing Opioids for Chronic Pain not meant to limit access to appropriate pain management for individuals with cancer, sickle cell disease
Oncology professionals from all over the world met in Orlando for the NCCN 2019 Annual Conference to discuss how to better address the needs of people with cancer. Join the conversation online with the hashtag #NCCNac19.
NCCN presents awards to Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Margaret A. Tempero, MD, UCSF Helen Diller Family Comprehensive Cancer Center; Richard Hoppe, MD, Stanford Cancer Institute; Michael Kolodziej, MD, ADVI; and Jennifer Burns, NCCN, during NCCN 2019 Annual Conference.
MD Anderson’s Dr. Ronald Walters elected chair of the Board for National Comprehensive Cancer Network; UW Carbone’s Ruth O’Regan elected Vice-Chair.
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) and Eli Lilly and Company (NYSE: LLY) today announced six projects that aim to improve the delivery of gastric and gastroesophageal junction (GEJ) cancer care in the United States.
New research from Duke University, published in the March 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, provides evidence that genomic recurrence score (RS) testing using the 21-gene assay is associated with lower costs for people with clinically high-risk breast cancer.
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has funded three investigators from NCCN Member Institutions through a collaborative scientific research relationship with Taiho Oncology, Inc.
More than 1,500 cancer care professionals are meeting in Orlando, Florida, March 21-23, for the NCCN 2019 Annual Conference, presented by the National Comprehensive Cancer Network® (NCCN®)—an alliance of 28 leading cancer centers.
New NCCN Guidelines for Patients: Squamous Cell Skin Cancer explains risk factors and treatment options for cancer type that impacts millions every year.
Study in JNCCN finds coronary artery disease costs increase dramatically in patients who are diagnosed with cancer.
The National Comprehensive Cancer Network® (NCCN®) announces formal endorsements from the governments of Ethiopia, Nigeria, and Tanzania for the NCCN Harmonized Guidelines™ for Sub-Saharan Africa, while joining cancer leaders across the globe to raise awareness and take action for World Cancer Day on February 4.
The National Comprehensive Cancer Network® (NCCN®) has published updated resources for improving and facilitating quality, effective, efficient, and accessible cancer care in the Middle East and North Africa (MENA).
Researchers from Yale School of Public Health find that genetic profiling for cancer tumors is cost-effective for high- and medium-risk patients with breast cancer, but is unlikely to make a meaningful impact on treatment for low-risk patients, in study published in January 2019 issue of JNCCN-Journal of the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) were downloaded more than 10 million times in 2018; marking a 26% increase over 2017.
Findings published in JNCCN-Journal of the National Comprehensive Cancer Network examine the differences between patient- and clinician-reported outcomes; recommend a greater focus on the cumulative effect of multiple low-level toxicities.
Advocates, patients, providers, and other experts examine disparities and explore solution at the NCCN Patient Advocacy Summit on Equity in Cancer Care
NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment
The Abramson Cancer Center joins 27 other leading academic cancer centers from across the United States in creating the most frequently updated cancer care guidelines worldwide, as an NCCN Member Institution.
NCCN Guidelines for Patients®: Oral Cancers provides information about mouth cancers for patients and caregivers.
New research published in JNCCN-Journal of the National Comprehensive Cancer Network found Latino men were 21% less likely to receive definitive treatment compared to non-Latino white men, with significant differences for younger patients, the uninsured, and those treated at NCI-designated centers.
New agreement between National Comprehensive Cancer Network and Syapse will augment health information technology around precision medicine and biomarkers in cancer care
The National Comprehensive Cancer Network’s Oncology Research Program received a grant to investigate effectiveness of trifluridine and tipiracil for treatment of people with colorectal, gastric, and other cancers
NCCN publishes updated patient and clinical guidelines for breast cancer in conjunction with free webinars. New NCCN Harmonized Guidelines for the Caribbean released for breast cancer and other types. Global Summit on International Breast Health and Cancer Control begins.
New NCCN Guidelines for Patients: NET provides background and treatment information for neuroendocrine tumors, the type of cancer experienced by Aretha Franklin and Steve Jobs
National Comprehensive Cancer Network (NCCN) moves into new global headquarters in Plymouth Meeting, PA, in the Greater Philadelphia area, less than three hour's drive from Washington, D.C., New York City, and Princeton, NJ.
Researchers from Netherlands Cancer Institute recommend qualitative and quantitative measurements that can lead to more successfully coordinated cancer care, finds need for better organization around the integration of care, according to article in September 2018 issue of JNCCN-Journal of the Comprehensive Cancer Network.
National Comprehensive Cancer Network convenes Policy Summit to address changing care paradigms, and the impact across the cancer care continuum
NCCN Oncology Research Program puts out request for proposals (RFP) for innovative strategies to improve patient outcomes for people with gastric and gastroesophageal junction cancer. Letters of intent due October 24.
National Comprehensive Cancer Network publishes NCCN Guidelines for Patients: Uterine Cancer during Gynecologic Cancer Awareness Month to explain treatment options and raises awareness of endometrial cancer, the most common type of gynecologic cancer.
Study from the American Cancer Society, published in JNCCN--Journal of the National Comprehensive Cancer Network, found cancer patients who were more satisfied with the communication they received, had better health results at lower costs
New NCCN Guidelines for gestational trophoblastic neoplasia created to ensure pregnant women with cancer receive life-saving treatment while preserving fertility
JNCCN—Journal of the National Comprehensive Cancer Network introduces new Executive Editorial Board, reaches new heights for readership and impact rating thanks to expanding content, including new studies, panel insights, and NCCN Guidelines®
New Study in JNCCN focuses on women under 40 with breast cancer finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence of any residual invasive tumor (pathologic complete response).
NCCN convenes summit on providing high-quality cancer care in an evolving policy and tech landscape, featuring FDA Chairman Scott Gottlieb, Co-Chairs of the Congressional Survivors Caucus, Congressmen Mark DeSaulnier and Ted Poe, and new data on the impact of narrow networks on cancer care delivery.
In new study in JNCCN - Journal of the National Comprehensive Cancer Network, Netherlands-based researchers found emergency colon cancer surgery was more likely to lead to complications if performed on a weekend, rather than a weekday.
National Comprehensive Cancer Network releases new patient guidelines for liver, gallbladder, and bile duct (hepatobiliary) cancers, sponsored by the Global Liver Institute.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right